Personal CFO Solutions’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-7,258
| Closed | -$229K | – | 418 |
|
|
2022
Q2 | $229K | Sell |
7,258
-3,239
| -31% | -$102K | 0.05% | 347 |
|
|
2022
Q1 | $482K | Sell |
10,497
-3,671
| -26% | -$169K | 0.1% | 207 |
|
|
2021
Q4 | $868K | Sell |
14,168
-4,448
| -24% | -$273K | 0.16% | 125 |
|
|
2021
Q3 | $1.39M | Sell |
18,616
-508
| -3% | -$38K | 0.29% | 68 |
|
|
2021
Q2 | $1.77M | Sell |
19,124
-1,311
| -6% | -$121K | 0.36% | 52 |
|
|
2021
Q1 | $1.81M | Buy |
20,435
+5,926
| +41% | +$526K | 0.39% | 53 |
|
|
2020
Q4 | $1.35M | Buy |
14,509
+8,123
| +127% | +$757K | 0.33% | 63 |
|
|
2020
Q3 | $0 | Buy |
+6,386
| New | – | ﹤0.01% | 146 |
|